Build status - In Progress

Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide (ACCESS)

Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide (ACCESS)
Recruiting
18 years - 65 years
All
Phase N/A
180 participants needed
1 Location

Brief description of study

This is a prospective, multi-center, Phase II study of hematopoietic cell transplantation using human leukocyte antigen-mismatched unrelated donors for peripheral blood stem cell transplant in adults and bone marrow stem cell transplant in children.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Blood Transplant Marrow TransplantLeukemiaLymphoma
  • Age: 18 years - 65 years
  • Gender: All

Age 1-66 Diagnosis of Leukemia

Online study
Updated on 20 Feb 2025. Study ID: 849440

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center